Guidant’s Drug-Eluting Stent Program Reboots With 140-Patient Dose Trial
This article was originally published in The Gray Sheet
Executive Summary
The need to perform dosing studies before attempting a large-scale clinical trial of a drug-eluting coronary stent is demonstrated by early results of Guidant's DELIVER trial, Angiotech maintains